PMGC HOLDINGS INC. Deferred Tax Assets, Operating Loss Carryforwards
PMGC HOLDINGS INC. (ELAB) had Deferred Tax Assets, Operating Loss Carryforwards of $4.90 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.90M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.32M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $3.32M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.71M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $662.00K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $4.90M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $3.32M 10-K · filed 2026-03-30 | $3.32M 10-K · filed 2025-03-28 |
| 2023-12-31 | $1.71M 10-K · filed 2025-03-28 | |
| 2022-12-31 | $662.00K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |